Page 102 - THE EVOLUTION OF EARLY ARTHRITIS AND CARDIOVASCULAR RISK Samina A. Turk
P. 102
CHAPTER 5
Conduction
QTc, ms *
PQ, ms *
Cardiovascular risk factors
Current smoking, n (%)
BMI, kg/m2
Systolic BP, mmHg †
Diastolic BP, mmHg †
ABI †
TChol, mmol/l ‡
Triglycerides, mmol/l, median (IQR) ‡ LDL, mmol/l ‡
HDL, mmol/l ‡
TChol:HDL ratio ‡
413.0 (17.2) 152.1 (23.7)
154 (32.1) 26.4 (4.9) 134.1 (20.4) 80.1 (11.8) 1.0 (0.1)
5.1 (1.0)
1.1 (0.8-1.5) 3.2 (0.9)
1.4 (0.4)
4.0 (1.3)
* Patients who did not use β-blockers, n = 455. † Patients who did not use antihypertensive drugs, n = 360. ‡ Patients who did not use statins, n = 417.
ABI: ankle brachial index; ACPA: anticitrullinated protein antibodies; BMI: body mass index; BP: blood pressure; CRP: C-reactive protein; DAS28: 28-joint Disease Activity Score; ESR: erythrocyte sedimentation rate; HDL: high-density lipoprotein; HR: heart rate; IQR: interquartile range; LDL: low-density lipoprotein; QTc: QT corrected for heart rate; RF: rheumatoid factor; SJC: swollen joint count; SD: standard deviation; syst BP: systolic blood pressure; TChol: total cholesterol; TJC: tender joint count; VAS: visual analog scale
Figure 1. Distribution of total conduction disorders at baseline, n = 60 QTc: QT time corrected for heart rate
100
